![](/img/cover-not-exists.png)
A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors
R.T. PENSON, S.M. CAMPOS, M.V. SEIDEN, C. KRASNER, A.F. FULLER Jr, A. GOODMAN, M. ROCHE, A. WILLMAN, A. MUZIKANSKY, U.A. MATULONIS, Gynecologic Oncology Research Program at Dana Farber/Partners CancerVolume:
15
Year:
2005
Language:
english
Pages:
7
DOI:
10.1111/j.1525-1438.2005.00482.x
File:
PDF, 86 KB
english, 2005